Comments are Off
IID2013, Investigative Dermatology, NativeSkin
We are very pleased to announce that our technology NativeSkin will be presented in a nice study done by LEO Pharma and us at the International Investigative Dermatology annual meeting.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Shop – Europe & Middle-East
Shop – Asia & Pacific
Shop – United States & Canada
Terms & Conditions
Why testing and mitigating Injection Site Reactions is critical during drugs/vaccines development ?
25 April 2023
Join Genoskin as a Marketing & Communication intern
4 April 2023
Genoskin and PharmaJet Announce Strategic Research Partnership to Advance Precision Vaccine Delivery
1 April 2023
Vaccination Webinar – Behazine Combadiere – Naked Immunology 4
24 January 2023